EYPT vs FAST · rev $43.3M vs P/E 43, rev $7.55B
Eyepoint Pharmaceuticals Inc (EYPT) versus Fastenal Company (FAST) — a side-by-side from cached financials, not a winner call.
Eyepoint Pharmaceuticals Inc (EYPT) is a biotechnology company listed on NASDAQ.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Latest reported EYPT revenue for 2024-12-31 was $43.3M. Net income was -$130.9M. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. EYPT currently screens at market cap $1.10B.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
EYPT currently screens at market cap $1.10B. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Not investment advice. Open the EYPT and FAST stock pages for the full models.
Not investment advice.